-
Narrative Review of Total Quality-Adjusted Life Year (QALY) Gains From Oncology Medicines Reimbursed From 2020 To 2025 in Ireland
Sep 9, 2025, 16:22 PM -
Will Patient Input Shape EU-Level Health Technology Assessments? HTA Representative Perspectives on the EU HTA Regulation
Sep 9, 2025, 16:22 PM -
Climate Impact of CAR-T Cell Therapy in the Netherlands: A Comparison on the Use Phase Emission Between Standard of Care and CAR-T Cell Therapy in Hemato-oncology
Sep 9, 2025, 16:22 PM -
Impact on Prescribing Choice Following the Identification of Preferred Continuous Glucose Monitoring Sensors in the Irish Healthcare Setting
Sep 9, 2025, 16:22 PM -
Unlocking Access: Overcoming Barriers and Harnessing Enablers for Innovative Payment Models for Pharmaceutical Innovation in Europe
Sep 9, 2025, 16:22 PM -
What Are the Biggest Value Drivers? A Comparison of the Relative Impacts of Six Novel Value Elements on Value Estimates Across Twelve Treatments Through Generalized Cost-Effectiveness Analyses
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Ireland
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL for Vasomotor Symptoms Caused by Endocrine Therapy: Reliability, Validity, and Differential Item Functioning
Sep 9, 2025, 16:22 PM -
The Alignment Between Technology Incorporations and Actual Health Needs
Sep 9, 2025, 16:22 PM -
Negotiated Closed Budgets in Greece: A Case Study of Success in Enhancing Patient Access Whilst Achieving Savings
Sep 9, 2025, 16:22 PM -
The Impact of Intravesical Instillations on Quality of Life in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
Sep 9, 2025, 16:22 PM -
Improvements in Scalp Outcomes With Roflumilast Foam 0.3% for Psoriasis of the Scalp and Body From the Phase 3 ARRECTOR Trial
Sep 9, 2025, 16:22 PM -
Integrating Real-World Evidence for Advanced Therapies in Inflammatory Bowel Disease Into Reimbursement Submissions: Insights and Considerations From the UK
Sep 9, 2025, 16:22 PM -
Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization in Individuals With Phenylketonuria: A Retrospective Observational Study in the United States
Sep 9, 2025, 16:22 PM -
Multi-Level Factors Influencing Active Surveillance Initiation Among Elderly Medicare Beneficiaries Newly Diagnosed With Low-Risk and Favorable Intermediate-Risk Prostate Cancer: An Active Comparator New User Retrospective Cohort Study in the United...
Sep 9, 2025, 16:22 PM -
Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Antimicrobial Resistant Infections and Antibiotic Prescriptions in Greece
Sep 9, 2025, 16:22 PM -
Assessment of Oncology Analog HTA Outcomes and Evidence Needs in France and Germany
Sep 9, 2025, 16:22 PM -
Unintended Consequences of MFN Pricing: Global Access Risks and Revenue Impact
Sep 9, 2025, 16:22 PM -
Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Sep 9, 2025, 16:22 PM
